Healthcare

TRC Healthcare Launches Upgraded NatMed Pro to Further Support Evidence-Based Natural Medicine Use with Smarter Tools

DENVER, July 1, 2025 /PRNewswire/ -- TRC Healthcare, the leading provider of evidence-based medication-related resources, announced last week the launch…

6 months ago

“Cure the Causes” Healthcare Philosophy Receives Trademark Registration

Healthcare Philosophy Now Officially Protected as Global Movement Gains MomentumFranklin, Tennessee--(Newsfile Corp. - July 1, 2025) - "Cure the Causes,"…

6 months ago

GE HealthCare announces cash dividend for second quarter of 2025

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per…

6 months ago

GE HealthCare announces cash dividend for second quarter of 2025

CHICAGO--(BUSINESS WIRE)--The Board of Directors of GE HealthCare Technologies Inc. (Nasdaq: GEHC) today declared a cash dividend of $0.035 per…

6 months ago

HealingMaps and Advanced Behavioral Strategies Launch Healing Health Alliance, the First Group Purchasing Organization (GPO) Exclusively for Ketamine, Psychedelic Medicine and TMS Clinics

Miami, Florida--(Newsfile Corp. - July 1, 2025) - HealingMaps, the leading directory for ketamine, psychedelic-assisted therapy, and TMS clinics, and…

6 months ago

Aviv Clinics Partners with Koterra to Expand Veteran Access to Lifesaving TBI and PTSD Treatment

World-renowned brain treatment center is teaming up with a Tampa-based nonprofit to bring hyperbaric oxygen therapy treatments for Veterans across…

6 months ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

ST. LOUIS, July 01, 2025 (GLOBE NEWSWIRE) -- Stereotaxis (NYSE: STXS), a pioneer and global leader in surgical robotics for…

6 months ago

LiveWorld Releases First-Ever AI Brand Reputation Index for Leading OTC Brands

Study highlights how AI tools like ChatGPT are shaping reputation and consumer perception of leading OTC brandsCAMPBELL, Calif. and NEW…

6 months ago

Inmagene Doses First Patient in the ADAPTIVE Phase 2b Trial of IMG-007, a Nondepleting Anti-OX40 mAb with an Extended Half-life, in Patients with Moderate-to-Severe Atopic Dermatitis

The ADAPTIVE Phase 2b trial evaluates multiple dose regimens of IMG-007 in patients with moderate-to-severe atopic dermatitisTopline data expected in…

6 months ago

Visory Health Wins Gold at the 2025 Digital Health Awards

Award-winning health tech company brings prescription savings to over 38,700 pharmacies nationwideESTERO, Fla., July 01, 2025 (GLOBE NEWSWIRE) -- Visory…

6 months ago